{"database": "lobbying", "table": "lobbying_activities", "rows": [[2337397, "8ce5a9b4-fbd4-4d39-918a-b44b566a523f", "Q3", "CONNECT 4 STRATEGIES, LLC", 401103720, "AKCEA THERAPEUTICS, INC.", 2019, "third_quarter", "PHA", "FDA drug approval issues", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2019-09-28T14:55:14.820000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2337397"], "units": {}, "query_ms": 0.5790720460936427, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}